Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

LILY TALAKOUB

Allopathic & Osteopathic Physicians Dermatology

NPI
1801929773
CMS profile
354092
Location
MC LEAN, VA

General Payments · PY2018–2024

$27,546.59

  • Reported across 201 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$311.54

16 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

Nature of paymentAmountRecords
Food and Beverage $311.54 16

By paying entity

PY2024 · sorted by reported total

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $9,661.90 60
PY2019 $14,414.60 62
PY2020 $1,963.99 7
PY2021 $141.20 8
PY2022 $550.45 22
PY2023 $502.91 26
PY2024 $311.54 16

Payment records · PY2024 (16)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
Amgen Inc. $14.42 05/09/2024 Food and Beverage Undisputed 01/23/2026 1117395622 CMS
Arcutis Biotherapeutics, Inc. $16.83 11/22/2024 Food and Beverage Undisputed 01/23/2026 1121060141 CMS
Galderma Laboratories, L.P. $20.37 03/05/2024 Food and Beverage Undisputed 01/23/2026 1145331379 CMS
Incyte Corporation $21.78 06/10/2024 Food and Beverage Undisputed 01/23/2026 1141203959 CMS
Incyte Corporation $19.56 06/19/2024 Food and Beverage Undisputed 01/23/2026 1141251650 CMS
Incyte Corporation $24.20 09/03/2024 Food and Beverage Undisputed 01/23/2026 1141175950 CMS
Incyte Corporation $18.64 12/04/2024 Food and Beverage Undisputed 01/23/2026 1141252722 CMS
Lilly USA, LLC $16.38 02/28/2024 Food and Beverage Undisputed 01/23/2026 1135089765 CMS
Lilly USA, LLC $20.25 11/13/2024 Food and Beverage Undisputed 01/23/2026 1135151980 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $20.61 02/14/2024 Food and Beverage Undisputed 01/23/2026 1153813054 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $18.55 02/27/2024 Food and Beverage Undisputed 01/23/2026 1153813056 CMS
Ortho Dermatologics, a division of Bausch Health US, LLC $22.20 09/26/2024 Food and Beverage Undisputed 01/23/2026 1153813058 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $22.56 03/28/2024 Food and Beverage Undisputed 01/23/2026 1152174547 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $18.80 05/10/2024 Food and Beverage Undisputed 01/23/2026 1152174549 CMS
SUN PHARMACEUTICAL INDUSTRIES INC. $22.56 07/18/2024 Food and Beverage Undisputed 01/23/2026 1152174545 CMS
Verrica Pharmaceuticals Inc. $13.83 04/08/2024 Food and Beverage Undisputed 01/23/2026 1118387434 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.